Healing the Future: Zydus Lifesciences Backs Illexcor's Groundbreaking Sickle Cell Therapy

Unknown Apr 02, 2026 4 Views

Zydus Lifesciences has announced that its venture arm, Zynext Ventures, has invested in Illexcor Therapeutics. This strategic investment aims to advance a novel oral therapy for sickle cell disease, marking a significant step in Zydus' commitment to developing innovative treatments for rare a...

Stay Ahead – Explore Now! The Musk Factor: How Elon Views India's Satcom Market